Federal Circuit Expands Direct Patent Infringement Liability / FDA Issues Kardashian Warning
DC Client Alert - August 19, 2015
Federal Circuit Expands Direct Patent Infringement Liability
On August 13, 2015, the Court of Appeals for the Federal Circuit, sitting en banc, made new law on multi-actor infringement in Akamai Technologies, Inc. v. Limelight Networks, Inc., expanding liability under 35 U.S.C. § 271(a). The Court's ruling reinstates a 2008 jury verdict finding Limelight liable for infringement, awarding Akamai over $45 million in damages.
FDA Issues Warning Letter for Kardashian Social Media Posts Promoting Drug
The Food and Drug Administration (FDA) has issued a warning letter to the maker of an anti-morning sickness drug endorsed by Kim Kardashian in Instagram and Twitter posts.